Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Amag Pharma Receives Unsolicited Acquisition Offer(2)

By Pharmaceutical Processing | August 3, 2011

 

LEXINGTON,
Mass. (AP) — Shares of Amag Pharmaceuticals
Inc. jumped today in premarket trading, after the drugmaker said it received an
unsolicited buyout offer worth $381 million from MSMB Capital Management.

Amag, based in Lexington,
Mass., said MSMB proposed to buy
all of its outstanding stock for $18 per share in cash. That represents a
25-percent premium over the stock’s closing price Tuesday of $14.39.

Amag, which makes Feraheme for the treatment of iron
deficiency anemia in adults with chronic kidney disease, said its board will
carefully consider the proposal.

Shares climbed 14.7 percent, or $2.11, to $16.50 in
pre-market trading.

Last month, Amag said it will buy drugmaker Allos
Therapeutics Inc. for about $268 million in stock. The deal is designed to
bolster its commercial portfolio and cuts costs. That deal is expected to close
in the fourth quarter.

Under terms of that deal, Allos stockholders will get 0.1282
shares of Amag stock for each share of Allos. Amag shareholders will own about
61 percent of the combined company, while Allos stockholders will have 39
percent.

Amag will nominate five of the nine members of the new
company’s board, and its CEO, Dr. Brian J.G. Pereira, will serve as CEO of the
new company. Michael Narachi will remain chairman. The combined company will be
based in Lexington, Mass.

 

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE